Introduction
Cancers are typically identified by their tissue of origin. However, rare instances of "lineage infidelity" occur where tumors exhibit characteristics of a completely different organ. This paper describes a case of primary gastric (stomach) cancer in a 71-year-old male that mimicked hepatocellular carcinoma (liver cancer). Known as hepatoid adenocarcinoma, this aggressive variant presents significant diagnostic challenges, particularly in distinguishing it from liver metastases.
Case Presentation and Methods
A 71-year-old male presented with a gastric mass and remarkably high serum α-fetoprotein (AFP) levels of 35,000 ng/ml (normal <10 ng/ml). To characterize the tumor, researchers employed a multi-modal diagnostic approach:
- Exfoliative Cytology: Touch preparations (smears) were taken from biopsied gastric mucosa to examine cell cluster morphology.
- Histopathology: Standard H&E staining was used to analyze tissue architecture.
- Immunohistochemistry: The tumor was tested for liver-specific markers: AFP, Albumin (ALB), Prealbumin (PALB), and Transferrin (TF).
- Biochemical Analysis: Lectin-affinity immunoelectrophoresis analyzed the carbohydrate structure of the AFP to determine its "liver-like" binding affinity.
Key Findings
Morphological and Functional Mimicry
The tumor exhibited a distinct "biphasic" nature. One component resembled standard glandular gastric adenocarcinoma, while the predominant component consisted of large, polygonal cells arranged in sheets, nearly identical to primary liver cancer.
The "hepatoid" cells were functionally active, hijacking liver-specific genetic programs to produce proteins such as Albumin and Transferrin. Immunohistochemical staining confirmed that these markers, along with AFP, were localized specifically to the hepatoid regions.
Diagnostic Value of Cytology and AFP Fingerprinting
The authors emphasize that touch smear cytology can often identify the two distinct cell populations more clearly than standard biopsy sections. Furthermore, lectin-affinity testing revealed that 94.5% of the serum AFP was Concanavalin A-bound, a signature identical to AFP produced by primary liver tumors. This biochemical "fingerprint" confirmed the hepatoid nature of the gastric primary.
Clinical Outcome and Discussion
Despite diagnostic clarity, the disease was highly aggressive. The patient responded poorly to treatment and passed away shortly after admission. Autopsy confirmed the stomach as the primary site, with metastases to lymph nodes and the portal vein, while the liver parenchyma itself remained free of primary tumors.
Hepatoid adenocarcinoma of the stomach is rare, occurring in approximately 1.2% to 8.8% of AFP-producing gastric cancers. Its recognition is critical; when a gastric mass is accompanied by high serum AFP, clinicians must consider this diagnosis to differentiate it from simple liver metastasis, as prognosis and management strategies differ. Future research is needed to understand the biological triggers that cause gastric cells to adopt a hepatic phenotype.
Summary updated